NCT04466059
- Conditions
- Blood Cancer, Hematologic Diseases, Hematologic Malignancy, +16 more
- Locations
-
- MLL Munich Leukemia Laboratory Munich, Bavaria, Germany
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,146 public trials
2,034 recruiting studies
Lymphoproliferative Disorders trial results
Recruiting
CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
NCT06735495
- Conditions
- B-Cell Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +19 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT06083207
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Wollongong Private Hospital Wollongong, New South Wales, Australia
- Austin Hospital Heidelberg, Victoria, Australia
- St Vincent's Hospital Melbourne, Victoria, Australia
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT06698887
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Chonnam National University Hwasun Hospital Hwasun, Jeonranamdo, South Korea
- Seoul National University Hospital Seoul, Seoul-teukbyeolsi [Seoul], South Korea
- Asan Medical Center Seoul, Seoul-teukbyeolsi [Seoul], South Korea
- Samsung Medical Center Seoul, Seoul-teukbyeolsi [Seoul], South Korea
Recruiting
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
NCT06732232
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- China, Shanghai Mengchao Cancer Hospital Shanghai, China
NCT05934513
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
NCT06733987
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy
NCT06718270
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China
Recruiting
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
NCT05053607
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- University of Washington Seattle, Washington, United States
NCT06725524
- Conditions
- B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Ruijin Hospital Shanghai, China